OTC Drug Testing Services Class I, 510(k)-Exempt Under FDA Proposal
This article was originally published in The Gray Sheet
Executive Summary
Guidance on labeling for over-the-counter sample collection systems for drugs of abuse testing will be developed by FDA, the agency says in a March 5 downclassification proposal for the products.